Losartan-mediated regulation of phospholipid biosynthesis.
Hatch
G M
GM
Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Canada.
Lee
D
D
Man
R Y
RY
Kroeger
E A
EA
Choy
P C
PC
D000804:Angiotensin II / Q000378:metabolism / Q000494:pharmacology; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D002460:Cell Line; D002794:Choline / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D019808:Losartan / Q000494:pharmacology*; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D010713:Phosphatidylcholines / Q000037:antagonists & inhibitors*; D051381:Rats; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin / Q000378:metabolism*
D057911:Angiotensin Receptor Antagonists; D010713:Phosphatidylcholines; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D019808:Losartan; D002794:Choline